The safest approach is to consult a qualified dermatologist and focus on long-term skin health rather than quick whitening results.
A phase I/II clinical trial found that the most common side effects were mild and transient (Teichman et al., 2006): Injection site reactions (redness, mild swelling) Headaches Flushing or warmth Temporary water retention Joint tightness or tingling Transient fatigue or dizziness Serious adverse events are rare when the peptide is used under medical supervision at appropriate doses
6j), confirming the dependency of GSH-deficient FoB on glycolysis
Reiter, J., Herker, E., Madeo, F
Semaglutide (Ozempic) Long-acting Dosage Initial: 0.25 mg subcutaneous injection once weekly for four weeks
This further illustrates that published animal-model work is often endpoint-specific rather than a comprehensive toxicology assessment